Drugmakers accused of fixing prices of multiple sclerosis drug
MLex Summary: A class action complaint has been filed on behalf of independent resellers against Lannett and other pharmaceutical companies for allegedly fixing the prices of the multiple sclerosis drug Baclofen.See...To view the full article, register now.
Already a subscriber? Click here to view full article